ESR1 and breast carcinoma: Furthermore, its aggressiveness and resistance to cell death are associated with the absence of the estrogen receptor (ER-) [38] and the overexpression of HSP70 [39,40], a chaperone system protein associated with lymph node metastases, decreased survival, and resistance to chemotherapy in breast cancer [46].